The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Immunoglobulin-Global Market Insights and Sales Trends 2025
Synopsis
The global Immunoglobulin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Immunoglobulin in various end use industries. The expanding demands from the Prevention of Measles, Infectious Hepatitis and Primary Immunoglobulin Deficiency,, are propelling Immunoglobulin market. Intramuscular Injection Human Immunoglobulin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Intravenous Injection Human Immunoglobulin segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Immunoglobulin market, driven by demand from China, the second largest economy with some signs of stabilising, the Immunoglobulin market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immunoglobulin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immunoglobulin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immunoglobulin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immunoglobulin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immunoglobulin covered in this report include Baxter, CSL, Grifols, Octapharma, Biotest, China National Pharmaceutical Group, CTBB, Hualan Bio and RAAS, etc.
The global Immunoglobulin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Baxter
CSL
Grifols
Octapharma
Biotest
China National Pharmaceutical Group
CTBB
Hualan Bio
RAAS
Shanxi Kangbao Biological
Shuanglin Bio Pharm
Sichuan Yuanda Shuyang Pharmaceutical
Boya Bio
Jiade Bio
Weilun Bio
Global Immunoglobulin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immunoglobulin market, Segment by Type:
Intramuscular Injection Human Immunoglobulin
Intravenous Injection Human Immunoglobulin
Global Immunoglobulin market, by Application
Prevention of Measles
Infectious Hepatitis
Primary Immunoglobulin Deficiency
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Immunoglobulin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Immunoglobulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Immunoglobulin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Immunoglobulin in various end use industries. The expanding demands from the Prevention of Measles, Infectious Hepatitis and Primary Immunoglobulin Deficiency,, are propelling Immunoglobulin market. Intramuscular Injection Human Immunoglobulin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Intravenous Injection Human Immunoglobulin segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Immunoglobulin market, driven by demand from China, the second largest economy with some signs of stabilising, the Immunoglobulin market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immunoglobulin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immunoglobulin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immunoglobulin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immunoglobulin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immunoglobulin covered in this report include Baxter, CSL, Grifols, Octapharma, Biotest, China National Pharmaceutical Group, CTBB, Hualan Bio and RAAS, etc.
The global Immunoglobulin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Baxter
CSL
Grifols
Octapharma
Biotest
China National Pharmaceutical Group
CTBB
Hualan Bio
RAAS
Shanxi Kangbao Biological
Shuanglin Bio Pharm
Sichuan Yuanda Shuyang Pharmaceutical
Boya Bio
Jiade Bio
Weilun Bio
Global Immunoglobulin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immunoglobulin market, Segment by Type:
Intramuscular Injection Human Immunoglobulin
Intravenous Injection Human Immunoglobulin
Global Immunoglobulin market, by Application
Prevention of Measles
Infectious Hepatitis
Primary Immunoglobulin Deficiency
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Immunoglobulin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Immunoglobulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Immunoglobulin Market Overview
1.1 Immunoglobulin Product Overview
1.2 Immunoglobulin Market Segment by Type
1.2.1 Intramuscular Injection Human Immunoglobulin
1.2.2 Intravenous Injection Human Immunoglobulin
1.3 Global Immunoglobulin Market Size by Type
1.3.1 Global Immunoglobulin Market Size Overview by Type (2018-2029)
1.3.2 Global Immunoglobulin Historic Market Size Review by Type (2018-2023)
1.3.3 Global Immunoglobulin Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Immunoglobulin Sales Breakdown by Type (2018-2023)
1.4.2 Europe Immunoglobulin Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Immunoglobulin Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Immunoglobulin Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Immunoglobulin Sales Breakdown by Type (2018-2023)
2 Global Immunoglobulin Market Competition by Company
2.1 Global Top Players by Immunoglobulin Sales (2018-2023)
2.2 Global Top Players by Immunoglobulin Revenue (2018-2023)
2.3 Global Top Players by Immunoglobulin Price (2018-2023)
2.4 Global Top Manufacturers Immunoglobulin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Immunoglobulin Market Competitive Situation and Trends
2.5.1 Immunoglobulin Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Immunoglobulin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immunoglobulin as of 2022)
2.7 Date of Key Manufacturers Enter into Immunoglobulin Market
2.8 Key Manufacturers Immunoglobulin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Immunoglobulin Status and Outlook by Region
3.1 Global Immunoglobulin Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Immunoglobulin Historic Market Size by Region
3.2.1 Global Immunoglobulin Sales in Volume by Region (2018-2023)
3.2.2 Global Immunoglobulin Sales in Value by Region (2018-2023)
3.2.3 Global Immunoglobulin Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Immunoglobulin Forecasted Market Size by Region
3.3.1 Global Immunoglobulin Sales in Volume by Region (2024-2029)
3.3.2 Global Immunoglobulin Sales in Value by Region (2024-2029)
3.3.3 Global Immunoglobulin Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Immunoglobulin by Application
4.1 Immunoglobulin Market Segment by Application
4.1.1 Prevention of Measles
4.1.2 Infectious Hepatitis
4.1.3 Primary Immunoglobulin Deficiency
4.2 Global Immunoglobulin Market Size by Application
4.2.1 Global Immunoglobulin Market Size Overview by Application (2018-2029)
4.2.2 Global Immunoglobulin Historic Market Size Review by Application (2018-2023)
4.2.3 Global Immunoglobulin Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Immunoglobulin Sales Breakdown by Application (2018-2023)
4.3.2 Europe Immunoglobulin Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Immunoglobulin Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Immunoglobulin Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Immunoglobulin Sales Breakdown by Application (2018-2023)
5 North America Immunoglobulin by Country
5.1 North America Immunoglobulin Historic Market Size by Country
5.1.1 North America Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Immunoglobulin Sales in Volume by Country (2018-2023)
5.1.3 North America Immunoglobulin Sales in Value by Country (2018-2023)
5.2 North America Immunoglobulin Forecasted Market Size by Country
5.2.1 North America Immunoglobulin Sales in Volume by Country (2024-2029)
5.2.2 North America Immunoglobulin Sales in Value by Country (2024-2029)
6 Europe Immunoglobulin by Country
6.1 Europe Immunoglobulin Historic Market Size by Country
6.1.1 Europe Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Immunoglobulin Sales in Volume by Country (2018-2023)
6.1.3 Europe Immunoglobulin Sales in Value by Country (2018-2023)
6.2 Europe Immunoglobulin Forecasted Market Size by Country
6.2.1 Europe Immunoglobulin Sales in Volume by Country (2024-2029)
6.2.2 Europe Immunoglobulin Sales in Value by Country (2024-2029)
7 Asia-Pacific Immunoglobulin by Region
7.1 Asia-Pacific Immunoglobulin Historic Market Size by Region
7.1.1 Asia-Pacific Immunoglobulin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Immunoglobulin Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Immunoglobulin Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Immunoglobulin Forecasted Market Size by Region
7.2.1 Asia-Pacific Immunoglobulin Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Immunoglobulin Sales in Value by Region (2024-2029)
8 Latin America Immunoglobulin by Country
8.1 Latin America Immunoglobulin Historic Market Size by Country
8.1.1 Latin America Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Immunoglobulin Sales in Volume by Country (2018-2023)
8.1.3 Latin America Immunoglobulin Sales in Value by Country (2018-2023)
8.2 Latin America Immunoglobulin Forecasted Market Size by Country
8.2.1 Latin America Immunoglobulin Sales in Volume by Country (2024-2029)
8.2.2 Latin America Immunoglobulin Sales in Value by Country (2024-2029)
9 Middle East and Africa Immunoglobulin by Country
9.1 Middle East and Africa Immunoglobulin Historic Market Size by Country
9.1.1 Middle East and Africa Immunoglobulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Immunoglobulin Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Immunoglobulin Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Immunoglobulin Forecasted Market Size by Country
9.2.1 Middle East and Africa Immunoglobulin Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Immunoglobulin Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Baxter
10.1.1 Baxter Company Information
10.1.2 Baxter Introduction and Business Overview
10.1.3 Baxter Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Baxter Immunoglobulin Products Offered
10.1.5 Baxter Recent Development
10.2 CSL
10.2.1 CSL Company Information
10.2.2 CSL Introduction and Business Overview
10.2.3 CSL Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
10.2.4 CSL Immunoglobulin Products Offered
10.2.5 CSL Recent Development
10.3 Grifols
10.3.1 Grifols Company Information
10.3.2 Grifols Introduction and Business Overview
10.3.3 Grifols Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Grifols Immunoglobulin Products Offered
10.3.5 Grifols Recent Development
10.4 Octapharma
10.4.1 Octapharma Company Information
10.4.2 Octapharma Introduction and Business Overview
10.4.3 Octapharma Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Octapharma Immunoglobulin Products Offered
10.4.5 Octapharma Recent Development
10.5 Biotest
10.5.1 Biotest Company Information
10.5.2 Biotest Introduction and Business Overview
10.5.3 Biotest Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Biotest Immunoglobulin Products Offered
10.5.5 Biotest Recent Development
10.6 China National Pharmaceutical Group
10.6.1 China National Pharmaceutical Group Company Information
10.6.2 China National Pharmaceutical Group Introduction and Business Overview
10.6.3 China National Pharmaceutical Group Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
10.6.4 China National Pharmaceutical Group Immunoglobulin Products Offered
10.6.5 China National Pharmaceutical Group Recent Development
10.7 CTBB
10.7.1 CTBB Company Information
10.7.2 CTBB Introduction and Business Overview
10.7.3 CTBB Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
10.7.4 CTBB Immunoglobulin Products Offered
10.7.5 CTBB Recent Development
10.8 Hualan Bio
10.8.1 Hualan Bio Company Information
10.8.2 Hualan Bio Introduction and Business Overview
10.8.3 Hualan Bio Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Hualan Bio Immunoglobulin Products Offered
10.8.5 Hualan Bio Recent Development
10.9 RAAS
10.9.1 RAAS Company Information
10.9.2 RAAS Introduction and Business Overview
10.9.3 RAAS Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
10.9.4 RAAS Immunoglobulin Products Offered
10.9.5 RAAS Recent Development
10.10 Shanxi Kangbao Biological
10.10.1 Shanxi Kangbao Biological Company Information
10.10.2 Shanxi Kangbao Biological Introduction and Business Overview
10.10.3 Shanxi Kangbao Biological Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Shanxi Kangbao Biological Immunoglobulin Products Offered
10.10.5 Shanxi Kangbao Biological Recent Development
10.11 Shuanglin Bio Pharm
10.11.1 Shuanglin Bio Pharm Company Information
10.11.2 Shuanglin Bio Pharm Introduction and Business Overview
10.11.3 Shuanglin Bio Pharm Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Shuanglin Bio Pharm Immunoglobulin Products Offered
10.11.5 Shuanglin Bio Pharm Recent Development
10.12 Sichuan Yuanda Shuyang Pharmaceutical
10.12.1 Sichuan Yuanda Shuyang Pharmaceutical Company Information
10.12.2 Sichuan Yuanda Shuyang Pharmaceutical Introduction and Business Overview
10.12.3 Sichuan Yuanda Shuyang Pharmaceutical Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Sichuan Yuanda Shuyang Pharmaceutical Immunoglobulin Products Offered
10.12.5 Sichuan Yuanda Shuyang Pharmaceutical Recent Development
10.13 Boya Bio
10.13.1 Boya Bio Company Information
10.13.2 Boya Bio Introduction and Business Overview
10.13.3 Boya Bio Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Boya Bio Immunoglobulin Products Offered
10.13.5 Boya Bio Recent Development
10.14 Jiade Bio
10.14.1 Jiade Bio Company Information
10.14.2 Jiade Bio Introduction and Business Overview
10.14.3 Jiade Bio Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Jiade Bio Immunoglobulin Products Offered
10.14.5 Jiade Bio Recent Development
10.15 Weilun Bio
10.15.1 Weilun Bio Company Information
10.15.2 Weilun Bio Introduction and Business Overview
10.15.3 Weilun Bio Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Weilun Bio Immunoglobulin Products Offered
10.15.5 Weilun Bio Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Immunoglobulin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Immunoglobulin Industrial Chain Analysis
11.4 Immunoglobulin Market Dynamics
11.4.1 Immunoglobulin Industry Trends
11.4.2 Immunoglobulin Market Drivers
11.4.3 Immunoglobulin Market Challenges
11.4.4 Immunoglobulin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Immunoglobulin Distributors
12.3 Immunoglobulin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
